APLM Apollomics Inc.

Nasdaq N/A


$ 22.28 $ 0.00 (0 %)    

Tuesday, 18-Nov-2025 06:35:31 EST
QQQ $ 600.96 $ 0.00 (0 %)
DIA $ 463.97 $ 0.00 (0 %)
SPY $ 663.25 $ 0.00 (0 %)
TLT $ 89.30 $ 0.00 (0 %)
GLD $ 371.83 $ 0.00 (0 %)
$ 21.45
$ 24.80
$ 12.00 x 17
$ 22.20 x 1
-- - --
$ 3.66 - $ 42.12
38,778
na
23.67M
$ 0.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 apollomics-receives-39m-payment-from-launxp-maintains-active-collaboration-on-vebreltinib-development

Pursuant to the Company's Form 6-K filed on July 25, 2025 (the "July 2025 6-K"), Apollomics Inc. ("Apollomics&#...

 nasdaq-cancels-delisting-hearing-for-apollomics-confirms-compliance-with-continued-listing-standards

Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a California based late-stage clinical biopharma...

Core News & Articles

The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading will resume in Apollomics Inc. Class A ordinary shares (NASDAQ:AP...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION